
Study Highlights
- A DNA vaccine helped lower blood pressure for up to six months, reduced tissue damage to the heart and blood vessels associated with hypertension in rats.
- If future research shows the vaccine is a viable treatment option in humans, it could improve high blood pressure levels.
A vaccine may one day help lower blood pressure for up to six months, according to new research in the American Heart Association’s journal Hypertension.
The study in rats may eventually provide a novel alternative to treat high blood pressure in people, who would not need to take a pill everyday.
“The potential of a vaccine for hypertension offers an innovative treatment that could be very effective for the control of non-compliance which is one of the major problems in the management of hypertensive patients,” said Hironori Nakagami M.D., Ph.D., study co-author and professor at Osaka University in Japan.
Researchers have designed a DNA vaccine that targets angiotensin II ? a hormone that raises blood pressure by causing blood vessels to constrict. This narrowing can increase your blood pressure and force your heart to work harder.
In the study, researchers immunized hypertensive rats three times at two-week intervals with needleless injections. The vaccine not only lowered blood pressure for up to six months, but also reduced tissue damage to the heart and blood vessels associated with hypertension. There were no signs of damage to other organs such as the kidney or liver.
The DNA vaccine works similar to common ACE inhibitor blood pressure medications which help blood vessels relax and open up, which, in turn, lowers blood pressure. Other types of vaccines have been tested for hypertension (e.g. a peptide vaccine), but didn’t have lasting effects and some had undesirable side effects.
The ultimate goal of an anti-hypertensive vaccine is to achieve perfect blood pressure control by improving drug compliance through the vaccine. In addition, in the developing countries like Africa and south Asia, anti-hypertensive drugs such as ARB (angiotensin receptor blockade) are expensive. A DNA vaccine may provide cheaper and effective anti-hypertensive treatments in such countries, researchers said.
Read more: Future vaccine may help lower blood pressure long-term
The Latest on: DNA vaccine
[google_news title=”” keyword=”DNA vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: DNA vaccine
- Evidence mounts that shingles vaccines protect against dementiaon July 25, 2024 at 10:52 am
Being immunised against shingles has been linked to a reduced dementia risk before and now a study suggests that the newer vaccine wards off the condition more effectively than an older one ...
- Shingles vaccine ‘may prevent dementia’, research findson July 25, 2024 at 8:48 am
In the study, Shingrix had a 17 per cent lower risk of dementia than Zostavax and a lower risk of between 23 and 27 per cent than vaccines against other infections, such as flu and tetanus. The ...
- Viral Vector And Plasmid DNA Market Updates : : Global Opportunity Analysis And Industry Forecast, 2023-2032on July 24, 2024 at 10:32 pm
Viral vectors and plasmid DNA are critical components in the development and production of gene therapies and vaccines, making them indispensable in modern biotechnology and pharmaceutical industries.
- Placebo outperformed HIV vaccine tested in SA, Uganda, Tanzania, study results showon July 24, 2024 at 7:54 am
A HIV vaccine test cancelled in November last year saw significantly higher rates of infection among those who received the shot compared to a placebo group, results made public this week show.
- HIV vaccines tested in PrEPVacc fail to reduce infectionson July 23, 2024 at 10:57 am
The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show conclusively that neither of the two experimental vaccine regimens tested ...
- PrEPVacc HIV vaccine trial shows no reduction in infectionson July 23, 2024 at 6:01 am
The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show conclusively that neither of the two experimental vaccine regimens tested ...
- Modified Self-Amplifying RNA Provides Opportunities For New Vaccines And Treatmentson July 23, 2024 at 5:00 am
An infectious disease physician discusses new research results that could lead to innovations in vaccines and treatments.
- How Messenger RNA Made The COVID Vaccines Possibleon June 6, 2024 at 8:59 pm
They had shown that they could in fact use mRNA to make enough protein to elicit an immune response, central to vaccine development. They had developed a powerhouse technique for copying DNA into gobs ...
- Scientists are making a 'groundbreaking' lung cancer vaccine that could prevent up to 90% of caseson March 21, 2024 at 4:53 pm
Neoantigens appear on the surface of the cell because of cancer-causing mutations within the cell's DNA. The LungVax vaccine will carry a strand of DNA which trains the immune system to recognise ...
- Florida surgeon general calls for halt in the use of COVID-19 mRNA vaccineson January 4, 2024 at 7:04 am
Florida Surgeon General Joseph Ladapo is urging residents in the Sunshine State to stop getting the Pfizer and Moderna mRNA COVID vaccines over what he says are DNA-related safety concerns.
via Bing News